DynaCirc CR Dosage
Generic name: ISRADIPINE 5mg
Dosage form: tablet, film coated, extended release
Medically reviewed on August 7, 2017.
The dosage of DYNACIRC CR Controlled Release Tablets should be individualized. The recommended initial dose of DYNACIRC CR is 5 mg once-daily as monotherapy or in combination with a thiazide diuretic. An antihypertensive response usually occurs within 2 hours, with the peak antihypertensive response occurring 8 to 10 hours post-dose; blood pressure reduction is maintained for at least 24 hours following drug administration. If necessary, the dose may be adjusted in increments of 5 mg at 2 to 4 week intervals up to a maximum dose of 20 mg/day. Adverse experiences are increased in frequency above 10 mg/day.
DYNACIRC CR Controlled Release Tablets should be swallowed whole and should not be bitten or divided.
The bioavailability (increased AUC) of immediate-release DYNACIRC is increased in elderly patients (older than 65 years of age), patients with hepatic functional impairment, and patients with mild renal impairment. Ordinarily, a starting dose of DYNACIRC CR 5 mg once-daily should be used in these patients.
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
More about DynaCirc CR (isradipine)
- DynaCirc CR Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- En Español
- 1 Review
- Drug class: calcium channel blocking agents